DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,573 | +3.1% | 1,804 | -0.3% | 0.24% | +3.5% |
| Q2 2023 | $434,160 | -6.2% | 1,809 | -1.5% | 0.23% | -17.6% |
| Q1 2023 | $462,996 | +95957.3% | 1,837 | +1.1% | 0.28% | -19.7% |
| Q4 2022 | $482 | -99.9% | 1,817 | +3.3% | 0.35% | +0.3% |
| Q3 2022 | $455,000 | +2.0% | 1,759 | 0.0% | 0.34% | +10.2% |
| Q2 2022 | $446,000 | -13.7% | 1,759 | -5.1% | 0.31% | +4.7% |
| Q1 2022 | $517,000 | -14.7% | 1,854 | +0.5% | 0.30% | -8.3% |
| Q4 2021 | $606,000 | +6.1% | 1,844 | -1.6% | 0.33% | +0.3% |
| Q3 2021 | $571,000 | -14.0% | 1,874 | -24.3% | 0.32% | -13.3% |
| Q2 2021 | $664,000 | +23.9% | 2,475 | 0.0% | 0.38% | +10.9% |
| Q1 2021 | $536,000 | -5.1% | 2,475 | -2.6% | 0.34% | -4.5% |
| Q4 2020 | $565,000 | +4.6% | 2,542 | +1.2% | 0.35% | -9.7% |
| Q3 2020 | $540,000 | +23.6% | 2,512 | +1.5% | 0.39% | +30.7% |
| Q2 2020 | $437,000 | -38.2% | 2,475 | -46.8% | 0.30% | +0.3% |
| Q1 2020 | $707,000 | +81.3% | 4,652 | +97.1% | 0.30% | -9.9% |
| Q4 2019 | $390,000 | – | 2,360 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |